Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM System
- ICU
- 06/06/2013
Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-cen
READ MORE